Geode Capital Management
CABA icon

Geode Capital Management’s Cabaletta Bio CABA Stock Holding History

Geode Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
3,459,464
+2,326,219
+205% +$7.65M ﹤0.01% 2494
2026
Q1 		$3.05M Buy
1,133,245
+47,429
+4% +$132K ﹤0.01% 2966
2025
Q4 		$2.38M Buy
1,085,816
+165,476
+18% +$410K ﹤0.01% 3103
2025
Q3 		$2.15M Buy
920,340
+366,878
+66% +$629K ﹤0.01% 3157
2025
Q2 		$842K Sell
553,462
-587,835
-52% -$917K ﹤0.01% 3385
2025
Q1 		$1.58M Buy
1,141,297
+30,595
+3% +$65.2K ﹤0.01% 3132
2024
Q4 		$2.52M Buy
1,110,702
+16,058
+1% +$56.4K ﹤0.01% 3048
2024
Q3 		$5.17M Buy
1,094,644
+124,071
+13% +$718K ﹤0.01% 2740
2024
Q2 		$7.26M Buy
970,573
+197,483
+26% +$2.42M ﹤0.01% 2519
2024
Q1 		$13.2M Buy
773,090
+19,914
+3% +$427K ﹤0.01% 2157
2023
Q4 		$17.1M Buy
753,176
+61,304
+9% +$1.03M ﹤0.01% 2008
2023
Q3 		$10.5M Buy
691,872
+189,145
+38% +$2.58M ﹤0.01% 2240
2023
Q2 		$6.49M Buy
502,727
+282,877
+129% +$3.07M ﹤0.01% 2552
2023
Q1 		$1.82M Sell
219,850
-11,415
-5% -$107K ﹤0.01% 3072
2022
Q4 		$2.14M Buy
231,265
+101,785
+79% +$371K ﹤0.01% 3008
2022
Q3 		$84K Hold
129,480
– – ﹤0.01% 4630
2022
Q2 		$137K Buy
129,480
+6,875
+6% +$9.72K ﹤0.01% 4448
2022
Q1 		$248K Sell
122,605
-1
-0% -$3 ﹤0.01% 4274
2021
Q4 		$464K Buy
122,606
+3,966
+3% +$42.3K ﹤0.01% 4093
2021
Q3 		$1.44M Buy
118,640
+978
+0.8% +$9.02K ﹤0.01% 3505
2021
Q2 		$1.01M Sell
117,662
-84,482
-42% -$830K ﹤0.01% 3598
2021
Q1 		$2.24M Buy
202,144
+25,836
+15% +$316K ﹤0.01% 3206
2020
Q4 		$2.2M Buy
176,308
+9,853
+6% +$128K ﹤0.01% 3030
2020
Q3 		$1.8M Sell
166,455
-18,245
-10% -$210K ﹤0.01% 2931
2020
Q2 		$2.06M Buy
184,700
+36,492
+25% +$279K ﹤0.01% 2819
2020
Q1 		$1.08M Buy
148,208
+37,434
+34% +$513K ﹤0.01% 2994
2019
Q4 		$1.55M Buy
+110,774
New +$1.31M ﹤0.01% 3116

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management's CABA Position: Q2 2026 in Review

Geode Capital Management increased its Cabaletta Bio (CABA) stake by 205% in Q2 2026, buying an estimated $7.65M and bringing the position to 3,459,464 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Geode Capital Management first reported a position in CABA in Q4 2019 and has held it in 27 quarters since. The position peaked at $17.1M in Q4 2023. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Geode Capital Management held 3,459,464 shares of Cabaletta Bio worth $10.8M as of Q2 2026.
  • Geode Capital Management bought 2,326,219 Cabaletta Bio shares in Q2 2026, an estimated $7.65M.
  • Cabaletta Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2494 holding.
  • Geode Capital Management first reported a position in Cabaletta Bio in Q4 2019 and has held it in 27 quarters since.
  • Geode Capital Management's Cabaletta Bio position peaked at $17.1M in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.